| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FNDC3B_0026500 | Exon-Exon | chr3:172070593-172080635 | chr3:172352803-172362845 | 494 nt | 0.5081 |
| hsa_FNDC3B_0026600 | Exon-Exon | chr3:172070593-172098883 | chr3:172352803-172381093 | 789 nt | 0.4918 |
| hsa_chr3_0368900 | Intergenic-Intergenic | chr3:172070623-172096188 | chr3:172352833-172378398 | 593 nt | 0.5008 |
| hsa_chr3_0369000 | Intergenic-Intergenic | chr3:172070832-172096092 | chr3:172353042-172378302 | 75 nt | 0.4533 |
| hsa_chr3_0369100 | Intergenic-Intergenic | chr3:172073540-172074662 | chr3:172355750-172356872 | 1123 nt | 0.4194 |
| hsa_FNDC3B_0026800 | Exon-Exon | chr3:172080423-172096226 | chr3:172362633-172378436 | 380 nt | 0.4842 |
| hsa_FNDC3B_0026900 | Exon-Exon | chr3:172080516-172098883 | chr3:172362726-172381093 | 415 nt | 0.4747 |
| hsa_chr3_0369200 | Intergenic-Intergenic | chr3:172080607-172115009 | chr3:172362817-172397219 | 196 nt | 0.5051 |
| hsa_chr3_0369300 | Intergenic-Intergenic | chr3:172081393-172081631 | chr3:172363603-172363841 | 239 nt | 0.4477 |
| hsa_FNDC3B_0027000 | Intron-Intron | chr3:172087860-172088007 | chr3:172370070-172370217 | 148 nt | 0.3243 |
A study in mice demonstrated that the circFNDC3B was significantly downregulated in hearts post-myocardial infarction and in human cardiac tissues of ischemic cardiomyopathy patients, where its overexpression in cardiac endothelial cells increased vascular endothelial growth factor expression, enhanced angiogenic activity, and reduced apoptosis [Tian et al. DOI:10.3390/molecules26041155].